INVIVO BIONICS AS

Operating

Utvikling, produksjon og konsulenttjenester for implanterbart medisinsk utstyr.

Tjenester innen konsulentvirksomhet, utvikling og produksjon av teknologi for alle typer medisinsk utstyr som har til hensikt å implanteres for diagnostikk eller behandling.

Keywords

engineering servicespowerenergytransportwatersewagedrainageindustrymanufacturingtelecommunicationsbroadcastingpolicy analysisregulationsexpert opinionswitness statementsmechanical engineeringautomotive engineeringchemical engineeringtechnical consulting

Organization

CEO: IC
Ingelin Clausen1964
Chairman of the board: SN
Stig Nordal1966
Years since formation: 8 years; since Feb 22, 2018
Type: Limited company
VAT registered: Yes
Number of employees: 7

Ownership

Number of shares and share classes: 486,449; 1 share class
Total number of shareholders: 30; 19 companies, 11 persons
Belongs to group of

Financials

Total operating income 2024: 7,103,171; NOK
Annual total result 2024: -11,898,277; NOK
Total equity 2024: 5,424,399; NOK

Last update: Jan 13, 2026

Locations

Company address
Gaustadalléen 21 0349 OSLO, Norge
Copied!
Postal address
Postboks 8600 Majorstuen 0349 OSLO, Norge
Copied!

Management

Management / administration

Name	Role	Shares
IC Ingelin Clausen 1964	Managing Director/CEO	49.47 % indirectly

Board

Name	Role	Shares
SN Stig Nordal 1966	Chairman	8.44 % indirectly
IC Ingelin Clausen 1964	Board Member	49.47 % indirectly
GE Gunnar Evensen 1962	Board Member	7.13 % indirectly
MÅ Morten Åsli 1974	Board Member	-

Others

Name	Role	Shares
F FORVIS MAZARS AS	Auditor	-
A AMICUS AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
IC Ingelin Clausen 1964	Managing Director/CEO, Board Member	49.47 % indirectly
JD Joachim Dericq Paasche 1974	-	9.25 % indirectly
SN Stig Nordal 1966	Chairman	8.44 % indirectly
GE Gunnar Evensen 1962	Board Member	7.13 % indirectly
JO John Olof Solberg 1972	-	4.6 % indirectly
TR Trond Riiber Knudsen 1964	-	2.08 % indirectly
RM Rasmus Michael Hansson 1972	-	1.04 % indirectly

Last update: Nov 5, 2025

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
I INGELIN CLAUSEN HOLDING AS	Ordinary shares	240,649	49.47 %
P PAASCHE HOLDING AS	Ordinary shares	45,000	9.25 %
F FELDEN AS	Ordinary shares	44,197	9.09 %
M MØSBU AS	Ordinary shares	34,252	7.04 %
S SOLBERG INVEST & CONSULT AS	Ordinary shares	22,361	4.6 %
M MP PENSJON PK	Ordinary shares	21,620	4.44 %
S STARTUPLAB FOUNDERS FUND III AS	Ordinary shares	20,673	4.25 %
T TRK GROUP AS	Ordinary shares	10,099	2.08 %
R RMH INVEST AS	Ordinary shares	5,050	1.04 %
H HUBBLE AS	Ordinary shares	4,324	0.89 %
G GEG INVEST AS	Ordinary shares	4,324	0.89 %
B BLUEFIELD AS	Ordinary shares	3,535	0.73 %
I INVIVO BIONICS AS	Ordinary shares	3,440	0.71 %
BA Bastos Aragao Daniel 1973	Ordinary shares	3,000	0.62 %
K KEEP ON ROCKING AS	Ordinary shares	2,525	0.52 %
B BERARD HOLDING AS	Ordinary shares	2,500	0.51 %
AL Anette Larssen Bratteberg 1974	Ordinary shares	2,284	0.47 %
K KROKUS INVEST AS	Ordinary shares	2,162	0.44 %
A ALUCO AS	Ordinary shares	2,162	0.44 %
F FRADJO AS	Ordinary shares	2,162	0.44 %
A AMICUS INVESTMENT AS	Ordinary shares	2,000	0.41 %
LG Lars Geir Whist Tvedt 1978	Ordinary shares	2,000	0.41 %
MC Martin Clausen Bekkelien 1992	Ordinary shares	1,998	0.41 %
OM Ole M Christoffersen 1986	Ordinary shares	1,500	0.31 %
IA Ilia Anatolyevich Bubnov 1988	Ordinary shares	1,500	0.31 %
PG Per Gerhard Gløersen 1941	Ordinary shares	432	0.09 %
SR Sayed Rahimi 1994	Ordinary shares	200	0.04 %
KC Krey Christian	Ordinary shares	200	0.04 %
GN Gustav Nimhed Carl 1995	Ordinary shares	200	0.04 %
IP Ivanou Pavel 1986	Ordinary shares	100	0.02 %

Shares owned by the INVIVO BIONICS AS

Name	Share class	Total number of shares	Share
U UROBIONICS AS	Ordinary shares	300,000	100 %
I INVIVO BIONICS AS	Ordinary shares	3,440	0.71 %

Last update: Jun 2, 2025

Group structure

INVIVO BIONICS AS
Total operating income 2024: NOK 7,103,171
Operating profit 2024: NOK -11,641,584
Employees: 7

Financials

in NOK

Summary

Year	2024	2023	2022	2021
Total operating income	7,103,171	25,059,981	7,062,566	4,170,583
Annual Total Result	-11,898,277	-1,123,422	-1,778,060	-1,137,017
Total assets	22,662,856	13,065,897	20,440,242	8,854,403
Total liabilities	17,238,458	8,332,264	15,094,336	1,715,979
Total equity	5,424,399	4,733,633	5,345,906	7,138,424

P&L

Year	2024	2023	2022	2021
Total operating income	7,103,171	25,059,981	7,062,566	4,170,583
Total operating costs	18,744,755	27,395,006	8,817,024	5,298,245
Operating result	-11,641,584	-2,335,025	-1,754,458	-1,127,662
Financial income/costs	-256,693	1,211,604	-23,602	-9,355
Profit before tax	-11,898,277	-1,123,422	-1,778,060	-1,137,017
Total tax & extraordinary income/cost	0	0	0	0
Annual Total Result	-11,898,277	-1,123,422	-1,778,060	-1,137,017

Balance overview

Year	2024	2023	2022	2021
Total fixed assets	10,351,606	5,997,095	4,861,227	2,318,606
Total current assets	12,311,250	7,068,802	15,579,015	6,535,797
Total assets	22,662,856	13,065,897	20,440,242	8,854,403
Short term debt	4,125,430	2,719,236	15,094,336	1,715,979
Long term debt	13,113,028	5,613,028	0	0
Total liabilities	17,238,458	8,332,264	15,094,336	1,715,979
Contributed capital	5,424,399	8,702,827	8,191,679	8,192,573
Retained earnings	0	-3,969,195	-2,845,773	-1,054,149
Total equity	5,424,399	4,733,633	5,345,906	7,138,424
Total equity and liabilities	22,662,856	13,065,897	20,440,242	8,854,403

Classification

21st company classification

BETA

Scaleup

INVIVO BIONICS AS920 478 840